Conley Alan J, Berger Trish, Caruso Casey J, Cotterman Rebecca F, Jones Tess, Christensen Bruce W, Hollinshead Fiona K, Place Ned J
1Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, CA.
2Department of Animal Science, College of Agricultural and Environmental Sciences, University of California-Davis, Davis, CA.
J Am Vet Med Assoc. 2024 Sep 11;263(2):227-234. doi: 10.2460/javma.24.06.0405. Print 2025 Feb 1.
To establish statistically valid, population-based reference intervals (RIs) for canine anti-Müllerian hormone (AMH) and define changes in AMH and inhibin-B in bitches during breeding cycles.
A homologous canine ELISA was used to measure AMH in serum samples (collected between May 2019 and July 2024) from 102 intact and 78 reportedly ovariohysterectomized (OVH) bitches and 8 bitches before and after ovariohysterectomy, and in longitudinal samples from 24 bitches undergoing breeding management. Established 95% RIs were used in a retrospective assessment of 3,193 clinical submissions. Cyclic variation of AMH and inhibin-B (heterologous ELISA) were regressed with time and normalized to the rise in progesterone in samples from breeding bitches.
Intact and OVH RIs for AMH were calculated with and without inclusion of 7 samples from reportedly OVH bitches that had AMH concentrations in the intact RI. Anti-Müllerian hormone and inhibin-B were positively correlated, and AMH was 3 times higher in proestrus than in estrus. Retrospectively, of 3,193 samples submitted for clinical AMH testing, 41% to 56% were in or above the intact AMH interval, 37% to 44% were within the OVH interval, and < 10% were inconclusive, depending on how RIs were defined.
Statistically valid, population-based RIs establish a sound basis for interpreting results of clinical submissions requesting AMH to assess gonadal status in the bitch.
Confirmation of cyclic variation in AMH (and, for the first time, inhibin-B) reaffirms proestrus as the optimum time to draw samples, and ≤ 10% of samples submitted for determination of gonadal status are expected to fall in an inconclusive AMH RI.
建立基于群体的、具有统计学有效性的犬抗缪勒氏管激素(AMH)参考区间(RIs),并确定母犬在繁殖周期中AMH和抑制素B的变化。
采用同源犬酶联免疫吸附测定法(ELISA),检测102只未绝育和78只据报道已进行卵巢子宫切除术(OVH)的母犬血清样本(于2019年5月至2024年7月采集)以及8只母犬卵巢子宫切除术前和术后的血清样本中的AMH,并检测24只接受繁殖管理的母犬的纵向样本中的AMH。已建立的95%参考区间用于对3193份临床送检样本进行回顾性评估。对繁殖期母犬样本中AMH和抑制素B(异源ELISA)的周期性变化与时间进行回归分析,并根据孕酮升高进行标准化。
计算了包含和不包含7份来自据报道已进行卵巢子宫切除术但AMH浓度处于未绝育参考区间的母犬样本的未绝育和卵巢子宫切除术后的AMH参考区间。抗缪勒氏管激素和抑制素B呈正相关,发情前期的AMH比发情期高3倍。回顾性分析显示,在提交进行临床AMH检测的3193份样本中,41%至56%处于或高于未绝育AMH区间,37%至44%处于卵巢子宫切除术后区间,不到10%的结果不确定,具体取决于参考区间的定义方式。
基于群体的、具有统计学有效性的参考区间为解释要求检测AMH以评估母犬性腺状态的临床送检结果奠定了坚实基础。
确认AMH(以及首次确认的抑制素B)的周期性变化再次证实发情前期是采集样本的最佳时间,预计提交用于性腺状态测定的样本中,不超过10%会处于不确定的AMH参考区间。